Chanca Piedra (Phyllanthus niruri): Benefits, Evidence, Dosage, and Safety

Chanca piedra—Spanish for “stone breaker”—is a small tropical plant (most commonly Phyllanthus niruri, though related Phyllanthus species are sometimes sold under the same name) used for centuries in traditional medicine across South America, India (Ayurveda), and parts of Southeast Asia. Today it’s best known as an herbal option people explore for kidney stones, but research has also examined its potential effects on liver health, inflammation, blood sugar, and infections.

This article summarizes traditional uses, what modern studies suggest, practical dosing guidance, and key safety considerations.

---

What is chanca piedra?

Chanca piedra refers to herbal preparations made from the aerial parts (and sometimes the whole plant) of Phyllanthus niruri. It contains a range of plant compounds—such as lignans (e.g., phyllanthin, hypophyllanthin), flavonoids, tannins, and phenolic acids—that may contribute to antioxidant, anti-inflammatory, and smooth-muscle–relaxing effects observed in laboratory studies.

Important note: Products labeled “chanca piedra” may contain different Phyllanthus species (e.g., P. amarus, P. fraternus). Effects may not be identical across species or extracts.

---

Traditional uses (how it’s been used historically)

Across traditional systems, chanca piedra has been used for:

• Kidney and urinary tract support: “gravel,” painful urination, urinary discomfort
• Liver and gallbladder complaints: jaundice, “liver cleansing,” digestive support
• Inflammation and pain: general anti-inflammatory and soothing uses
• Infections: folk use for viral and bacterial illnesses
• Blood sugar support: used in some traditions for “sweet urine”/diabetes-like symptoms

Traditional use doesn’t prove effectiveness, but it helps guide what researchers test.

---

Scientifically studied benefits (what the evidence says)

1) Kidney stones: prevention support and urinary effects (most studied)

Why it’s used: Kidney stones form when minerals crystallize (often calcium oxalate). Helpful strategies include increasing urine volume, reducing crystal formation, and reducing spasm/pain during stone passage.

What research suggests:

• May reduce stone-forming tendencies. Human and animal studies suggest chanca piedra may influence factors involved in calcium oxalate crystallization and stone “stickiness,” potentially making crystals less likely to grow or attach to urinary tract surfaces.
• May have antispasmodic (smooth muscle–relaxing) effects. This could theoretically ease ureteral spasm and discomfort, supporting stone passage—though it’s not a substitute for medical management.
• May affect urinary chemistry. Some studies report changes in urinary parameters relevant to stones, but results are mixed and depend on the population and preparation.

How strong is the evidence?
Promising but not definitive. There are small clinical studies and supportive preclinical work, but large, high-quality randomized trials are limited. It’s best viewed as a potential adjunct to standard prevention strategies (hydration, dietary changes, and prescribed medications when indicated).

Selected studies/reviews:

• Nishiura et al. evaluated Phyllanthus niruri in patients with urolithiasis (kidney stones), reporting effects on urinary parameters and stone-related outcomes in a clinical setting. (Exact outcomes vary by study design; overall suggests possible benefit but not conclusive.)
• Reviews of Phyllanthus species discuss antiurolithic mechanisms including effects on crystal aggregation and urinary tract smooth muscle. (See the review citations in the reference list below.)

(Because “chanca piedra” studies include different extracts/species and endpoints, outcomes can’t be summarized as one simple “works/doesn’t work.”)

---

2) Liver support (including viral hepatitis research)

Traditional context: Chanca piedra is widely used for “liver cleansing,” jaundice, and digestive complaints.

What research suggests:

• Antioxidant and anti-inflammatory liver protection in preclinical models. Animal studies show hepatoprotective effects against certain chemical-induced liver injuries, likely related to antioxidant activity and modulation of inflammatory pathways.
• Hepatitis B research is mixed. Phyllanthus extracts have been studied for effects on hepatitis B markers. Some early clinical research and lab studies suggested potential antiviral activity, but later analyses found inconsistent results, and it is not a substitute for evidence-based antiviral therapy.

Bottom line: There’s plausible liver-support potential, but for diagnosed liver disease (fatty liver, hepatitis, cirrhosis), chanca piedra should be considered only with clinician guidance and never as a replacement for medical treatment.

Selected evidence:

• Cochrane Review (Phyllanthus for chronic hepatitis B): concluded evidence was insufficient/uncertain due to study limitations and inconsistent findings.

---

3) Anti-inflammatory and antioxidant effects

What research suggests:

• Laboratory and animal studies consistently show antioxidant activity and anti-inflammatory effects (e.g., reductions in inflammatory mediators in certain models).
• These effects may help explain traditional use for pain/inflammation and may contribute indirectly to urinary and liver benefits.

Human evidence: limited. Most data are preclinical, so it’s best described as a potential mechanism rather than a proven clinical outcome.

---

4) Blood sugar and metabolic effects (emerging)

Some animal and small human studies of Phyllanthus species suggest possible blood glucose–lowering effects, but the evidence is not strong enough to recommend it as a diabetes treatment.

Practical implication: If you take glucose-lowering medications, chanca piedra could theoretically increase the risk of hypoglycemia—monitoring and clinician input are important.

---

5) Antimicrobial/antiviral activity (early-stage)

Extracts of Phyllanthus show antimicrobial and antiviral activity in lab studies. Translating this to meaningful clinical benefit in humans is still uncertain.

---

How to take chanca piedra (forms and typical dosages)

Because products vary widely (species, extraction method, strength), there is no single universally “correct” dose. However, common supplement approaches include:

Common forms

• Capsules/tablets (powdered herb or standardized extract)
• Tea (dried herb infusion)
• Tincture (alcohol or glycerin extract)

Typical adult dosing ranges (general supplement practice)

These are practical ranges used on labels and in herbal practice, not guaranteed therapeutic doses:

• Dried herb (tea/decoction): often 1–3 grams/day, sometimes divided, prepared as tea
• Capsules (powdered herb): commonly 500–1,000 mg, 1–2×/day
• Extracts: follow label directions; many provide the equivalent of 1–3 g/day of herb, depending on concentration

For kidney stone prevention: People often use it daily for weeks to months alongside hydration and dietary measures, but long-term daily use hasn’t been studied extensively for safety in large trials.

Tips for choosing a product

• Look for species verification (Phyllanthus niruri on the label) and third-party testing (USP, NSF, ConsumerLab, or equivalent).
• Avoid products with vague “proprietary blends” that don’t list the amount of chanca piedra.

---

Safety considerations, side effects, and who should avoid it

Chanca piedra is generally considered well-tolerated in typical supplemental amounts for many adults, but safety data are not as robust as for common medications.

Possible side effects

• Stomach upset, nausea, diarrhea
• Increased urination (mild diuretic effect in some people)
• Headache or dizziness (occasionally reported)

Potential interactions (important)

Because of possible effects on blood sugar, blood pressure, and clotting pathways in some Phyllanthus research:

• Diabetes medications/insulin: may enhance glucose-lowering → risk of hypoglycemia
• Blood pressure medications: may add to BP-lowering in sensitive individuals
• Anticoagulants/antiplatelets (e.g., warfarin, clopidogrel): theoretical interaction risk—use caution and consult a clinician
• Diuretics or lithium: any herb affecting urination/fluid balance can complicate dosing/levels (especially lithium)

Who should avoid or use only with medical supervision

• Pregnant or breastfeeding individuals (insufficient safety data)
• People with chronic kidney disease, one kidney, or recurrent complicated stones
• Anyone with liver disease or on hepatotoxic medications (not because it’s known to harm the liver, but because monitoring matters and products vary)
• People scheduled for surgery (consider stopping 1–2 weeks prior due to theoretical bleeding/glucose effects—confirm with your clinician)

When to seek medical care (don’t self-treat)

Kidney stones can become dangerous. Get urgent care if you have:

• Fever/chills, vomiting, severe unrelenting pain
• Blood in urine with weakness/lightheadedness
• Trouble urinating
• Known stone with signs of infection (this can be an emergency)

---

Practical takeaways (evidence-informed)

• Best-supported use: kidney stone support (especially prevention/recurrence risk factors), though evidence is still developing and not definitive.
• Potential additional benefits: liver-protective and anti-inflammatory effects are plausible, mostly supported by preclinical data and mixed human evidence.
• Most important “foundation” for stones still applies: hydration, dietary sodium reduction, adequate dietary calcium, and clinician-guided evaluation (stone analysis, 24-hour urine testing) when stones recur.
• Safety: generally well tolerated, but be cautious with diabetes meds, BP meds, anticoagulants, pregnancy, and chronic kidney disease.

---

References (selected)

Because the literature spans multiple Phyllanthus species and extract types, the references below include both clinical and high-level reviews:

1. Cochrane Database of Systematic Reviews – Phyllanthus species for chronic hepatitis B (systematic review; reports uncertainty/inconsistency across trials).
2. Nishiura JL, et al. Clinical investigations of Phyllanthus niruri in urolithiasis (kidney stone) patients, examining urinary parameters and stone-related outcomes. (Commonly cited in urolithiasis discussions; study designs vary.)
3. Review articles on antiurolithic activity of Phyllanthus (mechanisms: inhibition of calcium oxalate crystal growth/aggregation, effects on urinary tract smooth muscle, antioxidant effects).
4. Preclinical hepatoprotective studies of Phyllanthus niruri demonstrating antioxidant and anti-inflammatory effects in chemical-induced liver injury models.

If you want, tell me your goal (kidney stone prevention vs. active stone passage vs. general wellness), your age/sex, and any meds you take (especially BP, diabetes, or blood thinners), and I can suggest a more tailored, safety-first way to approach dosing and product selection.